COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1607: Articles 16061-16070  | Next

Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
Marc, A., Kerioui, M., Blanquart, F., Bertrand, J., Mitja, O., Corbacho-Monne, M., Marks, M., Guedj, J.
10.1101/2021.05.07.21256341 — Posted: 2021-05-08 Discussion: Onsite
Phylodynamic insights on the early spread of the COVID-19 pandemic and the efficacy of intervention measures
Gao, J., May, M. R., Rannala, B., Moore, B. R.
10.1101/2021.05.01.442286 — Posted: 2021-05-07
A hybrid PDE-ABM model for viral dynamics with application to SARS-CoV-2 and influenza
Marzban, S., Han, R., Juhasz, N., Röst, G.
10.1101/2021.05.07.443053 — Posted: 2021-05-07
Infection, recovery and re-infection of farmed mink with SARS-CoV-2
Rasmussen, T. B., Fonager, J., Jorgensen, C. S., Lassauniere, R., Hammer, A. S., Quaade, M. L., Boklund, A., Lohse, L., Strandbygaard, B., Rasmussen, M., Michaelsen, T. Y., Mortensen, S., Fomsgaard, A., Belsham, G. J., Botner, A.
10.1101/2021.05.07.443055 — Posted: 2021-05-07
Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques
Munster, V., Flagg, M., Singh, M., Williamson, B., Feldmann, F., Perez-Perez, L., Brumbaugh, B., Holbrook, M., Adney, D., Okumura, A., Hanley, P., Smith, B., Lovaglio, J., Anzick, S., Martens, C., van Doremalen, N., Saturday, G., de Wit, E.
10.1101/2021.05.07.443115 — Posted: 2021-05-07
A phylogeny-based metric for estimating changes in transmissibility from recurrent mutations in SARS-CoV-2
Richard, D., Shaw, L. P., Lanfear, R., Acman, M., Owen, C., Tan, C. C. S., van Dorp, L., Balloux, F.
10.1101/2021.05.06.442903 — Posted: 2021-05-07
poreCov - an easy to use, fast, and robust workflow for SARS-CoV-2 genome reconstruction via nanopore sequencing
Brandt, C., Krautwurst, S., Spott, R., Lohde, M., Jundzill, M., Marquet, M., Hölzer, M.
10.1101/2021.05.07.443089 — Posted: 2021-05-07
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
Mammen, M. P., Tebas, P., Agnes, J., Giffear, M., Kraynyak, K. A., Blackwood, E., Amante, D., Reuschel, E. L., Purwar, M., Christensen-Quick, A., Liu, N., Andrade, V. M., Carter, J., Garuffi, G., Diehl, M. C., Sylvester, A., Morrow, M. P., Pezzoli, P., Kulkarni, A. J., Zaidi, F. I., Frase, D., Liaw, K., Badie, H., Simon, K. O., Smith, T. R. F., Ramos, S., Spitz, R., Lee, J., Dallas, M., Shah Brown, A., Shea, J. E., Kim, J. J., Weiner, D. B., Broderick, K. E., Boyer, J. D., Humeau, L. M.
10.1101/2021.05.07.21256652 — Posted: 2021-05-07
Japan's Covid mitigation strategy and its epidemic prediction
Tokuda, Y., Kuniya, T.
10.1101/2021.05.06.21256476 — Posted: 2021-05-07
Precision Health Diagnostic and Surveillance Network uses S Gene Target Failure (SGTF) combined with sequencing technologies to identify emerging SARS-CoV-2 variants.
Guerrero-Preston, R., Rivera Amill, V., Caraballo, K., Arias Garcia, A., Sanchez Torres, R., Tadeu Zamuner, F., Zanettini, C., MacKay, M. J., Baits, R., Beaubier, N., Khullar, G., Metti, J., Pipic, U., Purcell-Wiltz, A., Vale, K., Perez, G., De Jesus, L., Miranda, Y., Ortiz, D., Garcia Negron, A., Viera, L., Ortiz, A., Acevedo, J., Romaguera, J., Jimenez, I., Marchionni, L., Rodriguez-Orengo, J., Baez, A., Mason, C. E., Sidransky, D.
10.1101/2021.05.04.21256012 — Posted: 2021-05-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).